BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/5/2024 10:19:29 AM | Browse: 175 | Download: 922
 |
Received |
|
2024-04-29 03:50 |
|
Peer-Review Started |
|
2024-04-29 03:50 |
|
First Decision by Editorial Office Director |
|
2024-05-15 19:37 |
|
Return for Revision |
|
2024-05-15 19:37 |
|
Revised |
|
2024-05-24 14:03 |
|
Publication Fee Transferred |
|
2024-06-13 14:41 |
|
Second Decision by Editor |
|
2024-06-11 02:51 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-06-11 13:49 |
|
Articles in Press |
|
2024-06-11 13:49 |
|
Edit the Manuscript by Language Editor |
|
2024-07-01 00:22 |
|
Typeset the Manuscript |
|
2024-07-01 09:56 |
|
Publish the Manuscript Online |
|
2024-07-05 10:19 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Pediatrics |
| Manuscript Type |
Retrospective Study |
| Article Title |
Evaluating the role of interleukin-2 and interleukin-12 in pediatric patients with concurrent Mycoplasma pneumoniae and Epstein-Barr virus infections
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Yan-Ping Hao |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Yan-Ping Hao, MBBS, Doctor, Doctor, Department of Pediatrics, Maternal and Child Health Hospital, No. 261 Shanhu Road, Shengzhou, Shaoxing 312400, Zhejiang Province, China. yanpingh0021@163.com |
| Key Words |
Interleukin-2; Interleukin-12; Mycoplasma pneumonia; Epstein-Barr virus; Coinfection |
| Core Tip |
This study presents a novel exploration of the interaction between immune response markers and co-infection outcomes in pediatric respiratory infections, focusing on Mycoplasma pneumoniae and Epstein-Barr virus. Our research addresses a critical gap in understanding the immunological dynamics in co-infected pediatric patients, offering insights into the prognostic values of interleukins interleukin-2 and interleukin-12. Through a comprehensive analysis of clinical data and a robust methodological approach, we provide evidence that serum levels of these cytokines are significantly associated with disease prognosis in co-infected individuals. The findings suggest a nuanced role of the immune system in managing co-infections, with potential implications for therapeutic strategies. |
| Publish Date |
2024-07-05 10:19 |
| Citation |
Hao YP. Evaluating the role of interleukin-2 and interleukin-12 in pediatric patients with concurrent Mycoplasma pneumoniae and Epstein-Barr virus infections. World J Clin Cases 2024; 12(23): 5346-5353
|
| URL |
https://www.wjgnet.com/2307-8960/full/v12/i23/5346.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v12.i23.5346 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
